The usage of melittin in breast cancer microenvironment targeting
DOI:
https://doi.org/10.47611/jsrhs.v12i1.3834Keywords:
breast cancer, melittin, microenvironments, cancer, cancer treatments, chemotherapy, hormone therapyAbstract
In today’s society, there are more people dying from breast cancer than ever. In fact, it has been projected that 1 in 39 women will die from breast cancer. Over the years, scientists have developed many forms of treatment to help alleviate some of the symptoms and keep the cancer at bay, such as chemotherapy and immunotherapy. Recently, however, a discovery has been made that could have the most efficacy and effectiveness against breast cancer. Melittin, a cationic peptide found in bee venom, is a 26 amino acid peptide that is being studied in many fields of medicine to be used as a new form of treatment in conjunction with the current forms. It is being tested in cancer research because of a special function that it has: the ability to start apoptosis by punching holes in the actual cell itself. In this paper, we will look at an overview of breast cancer’s history and statistics, look through some of the types of treatments that are already being used to fight breast cancer, and analyze five case studies to see how melittin can be used to target the microenvironments of breast cancer cells and figure out which method of treatment melittin will best fit into.
Downloads
References or Bibliography
References
Akhahenda, O. (2020, September 4). Figure 1. Lifeboat Foundation. Retrieved August 7, 2022, from https://lifeboat.com/blog/2020/09/melittin-a-major-peptide-component-of-bee-venom-and-its-conjugates-in-cancer-therapy
The American Cancer Society Medical and Editorial Content Team. (2022, January 12). Breast Cancer Statistics | How Common Is Breast Cancer? American Cancer Society. Retrieved August 7, 2022, from https://www.cancer.org/cancer/breast-cancer/about/how-common-is-breast-cancer.html
Breast Cancer Facts and Statistics. (2022, July 14). Breast Cancer.org. Retrieved August 7, 2022, from https://www.breastcancer.org/facts-statistics
Ceremuga, M., Stela, M., Janik, E., Gorniak, L., Synowiec, E., Sliwinski, T., Sitarek, P., Saluk-Bijak, J., & Bijak, M. (2020, February 6). Melittin-A Natural Peptide from Bee Venom Which Induces Apoptosis in Human Leukaemia Cells. PubMed. Retrieved August 7, 2022, from https://pubmed.ncbi.nlm.nih.gov/32041197/
Cleveland Clinic. (2022, May 18). Breast Cancer Surgery: Types, Procedure & Recovery. Cleveland Clinic. Retrieved August 7, 2022, from https://my.clevelandclinic.org/health/treatments/8338-breast-cancer-surgery
Cohen, E. (2020, October). What is Immunotherapy. Cancer Research Institute. Retrieved August 7, 2022, from https://www.cancerresearch.org/en-us/immunotherapy/what-is-immunotherapy
Duffy, C., Sorolla, A., Wang, E., Golden, E., Woodward, E., Davern, K., Ho, D., Johnstone, E., Pfleger, K., Redfern, A., Iyer, K. S., Baer, B., & Blancafort, P. (2020, September 1). Honeybee venom and melittin suppress growth factor receptor activation in HER2-enriched and triple-negative breast cancer. PubMed. Retrieved August 6, 2022, from https://pubmed.ncbi.nlm.nih.gov/32923684/
Ferreira, A.R., Meglio, A. D., Pistilli, B., Gbenou, A.S., El-Mouhebb, M., Dauchy, S., Charles, C., Joly, F., Everhard, S., Lambertini, M., Coutant, C., Cottu, P., Lerebours, F., Petit, T., Dalenc, F., Rouanet, P., Arnaud, A., Martin, A., Berille, J., … Vaz-Luis, I. (2019, November 1). Figure 4. Annals of Oncology. Retrieved August 7, 2022, from https://www.annalsofoncology.org/article/S0923-7534%2820%2932594-1/fulltext
Figure 3. (2014, September 16). Pixabay. Retrieved August 8, 2022, from https://pixabay.com/photos/chemotherapy-chemo-infusion-cancer-448578/
Gersten, T. (2012, October 15). Breast Cancer Now and Then: A Brief History. HealthCentral. Retrieved August 7, 2022, from https://www.healthcentral.com/slideshow/a-brief-history-of-breast-cancer
Hansel, W., & Leuschner, C. (2005, November 1). Targeting breast and prostate cancers through their hormone receptors. PubMed. Retrieved August 7, 2022, from https://pubmed.ncbi.nlm.nih.gov/16033998/
Hassani, Z. M., Nabiuni, M., Parivar, K., Abdirad, S., & Karimzadeh, L. (2021, June 2). Melittin inhibits the expression of key genes involved in tumor microenvironment formation by suppressing HIF-1α signaling in breast cancer cells. PubMed. Retrieved August 6, 2022, from https://pubmed.ncbi.nlm.nih.gov/34076777/
How Is Breast Cancer Treated? (2021, September 20). CDC. Retrieved August 7, 2022, from https://www.cdc.gov/cancer/breast/basic_info/treatment.htm
Ilic, L., Haidinger, G., Simon, J., Hackl, M., Schernhammer, E., & Papantoniou, K. (2022, April 29). Figure 2. scientific reports. Retrieved August 7, 2022, from https://www.nature.com/articles/s41598-022-10560-x
Inserm Press Office. (2019, October 9). Hormone therapy has a bigger impact than chemotherapy on women's quality of life. Salle de presse | Inserm. Retrieved August 7, 2022, from https://presse.inserm.fr/en/hormone-therapy-has-a-bigger-impact-than-chemotherapy-on-womens-quality-of-lifepact-plus-important-que-la-chimiotherapie-sur-la-qualite-de-vie-des-femmes/36900/
Johns Hopkins Medicine. (n.d.). Mastectomy. Johns Hopkins Medicine. Retrieved August 7, 2022, from https://www.hopkinsmedicine.org/health/conditions-and-diseases/breast-cancer/mastectomy
Kim, M.-G., Shon, Y., Kim, J., & Oh, Y.-K. (2016, September 11). Selective Activation of Anticancer Chemotherapy by Cancer-Associated Fibroblasts in the Tumor Microenvironment. PubMed. Retrieved August 6, 2022, from https://pubmed.ncbi.nlm.nih.gov/27615014/
Lee, C., Bae, S.-J. S., Joo, H., & Bae, H. (2017, June 27). Melittin suppresses tumor progression by regulating tumor-associated macrophages in a Lewis lung carcinoma mouse model. PubMed. Retrieved August 7, 2022, from https://pubmed.ncbi.nlm.nih.gov/28903394/
Liu, M., Wang, H., Liu, L., Wang, B., & Sun, G. (2016, June 1). Melittin-MIL-2 fusion protein as a candidate for cancer immunotherapy. PubMed. Retrieved August 6, 2022, from https://pubmed.ncbi.nlm.nih.gov/27246873/
Mayo Clinic Cancer Center. (2020, July 1). Figure 5. Mayo Clinic. Retrieved August 7, 2022, from https://www.mayoclinic.org/tests-procedures/radiation-therapy/about/pac-20385162
Mayo Clinic Staff. (2022, March 22). Chemotherapy. Mayo Clinic. Retrieved August 7, 2022, from https://www.mayoclinic.org/tests-procedures/chemotherapy/about/pac-20385033
National Cancer Institute. (2020, August 31). Milestones in Cancer Research and Discovery - NCI. National Cancer Institute. Retrieved August 7, 2022, from https://www.cancer.gov/research/progress/250-years-milestones
Plesca, M., Bordea, C., Houcheimi, B. E., Ichim, E., & Blidaru, A. (2016, June). Evolution of radical mastectomy for breast cancer. NCBI. Retrieved August 7, 2022, from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4863512/
Schneider, A. P., Zainer, C. M., Kubat, C. K., Mullen, N. K., & Windisch, A. K. (2014, August). The breast cancer epidemic: 10 facts - PMC. NCBI. Retrieved August 7, 2022, from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4135458/
Tipgomut, C., Wongprommoon, A., Takeo, E., Ittiudomrak, T., Puthong, S., & Chanchao, C. (2018, December 25). Melittin Induced G1 Cell Cycle Arrest and Apoptosis in Chago-K1 Human Bronchogenic Carcinoma Cells and Inhibited the Differentiation of THP-1 Cells into Tumour- Associated Macrophages. PubMed. Retrieved August 6, 2022, from https://pubmed.ncbi.nlm.nih.gov/30583665/
Wang, H., Li, J., Wang, Z., Wang, Y., Xu, X., Gong, X., Wang, J., Zhang, Z., & Li, Y. (2021, February). Tumor-permeated bioinspired theranostic nanovehicle remodels tumor immunosuppression for cancer therapy. PubMed. Retrieved August 6, 2022, from https://pubmed.ncbi.nlm.nih.gov/33378729/
What Are the Risk Factors for Breast Cancer? (2021, September 20). CDC. Retrieved August 7, 2022, from https://www.cdc.gov/cancer/breast/basic_info/risk_factors.htm
Yang, M., Li, J., Gu, P., & Fan, X. (2020, December 26). The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment. PubMed. Retrieved August 6, 2022, from https://pubmed.ncbi.nlm.nih.gov/33426371/
Published
How to Cite
Issue
Section
Copyright (c) 2023 Gaurav Ramasani, Dr. Raj
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Copyright holder(s) granted JSR a perpetual, non-exclusive license to distriute & display this article.
